# Angiotensin Converting Enzyme Inhibition in Children With Mitral Regurgitation

> **NCT00113698** · PHASE3 · TERMINATED · sponsor: **University of Utah** · enrollment: 5 (actual)

## Conditions studied

- Heart Defects, Congenital
- Heart Septal Defects, Ventricular
- Heart Failure, Congestive

## Interventions

- **DRUG:** Enalapril
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT00113698
- **Lead sponsor:** University of Utah
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2004-12
- **Primary completion:** 2005-11
- **Final completion:** 2006-01
- **Target enrollment:** 5 (ACTUAL)
- **Why stopped:** lower than expected enrollment
- **Last updated:** 2014-03-13

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00113698

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00113698, "Angiotensin Converting Enzyme Inhibition in Children With Mitral Regurgitation". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00113698. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*